Cargando…

Combination Therapy Strategies for the Treatment of Malaria

Malaria is a vector- and blood-borne infection that is responsible for a large number of deaths around the world. Most of the currently used antimalarial therapeutics suffer from drug resistance. The other limitations associated with the currently used antimalarial drugs are poor drug bioavailabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alven, Sibusiso, Aderibigbe, Blessing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804225/
https://www.ncbi.nlm.nih.gov/pubmed/31591293
http://dx.doi.org/10.3390/molecules24193601
_version_ 1783461135520890880
author Alven, Sibusiso
Aderibigbe, Blessing
author_facet Alven, Sibusiso
Aderibigbe, Blessing
author_sort Alven, Sibusiso
collection PubMed
description Malaria is a vector- and blood-borne infection that is responsible for a large number of deaths around the world. Most of the currently used antimalarial therapeutics suffer from drug resistance. The other limitations associated with the currently used antimalarial drugs are poor drug bioavailability, drug toxicity, and poor water solubility. Combination therapy is one of the best approaches that is currently used to treat malaria, whereby two or more therapeutic agents are combined. Different combination therapy strategies are used to overcome the aforementioned limitations. This review article reports two strategies of combination therapy; the incorporation of two or more antimalarials into polymer-based carriers and hybrid compounds designed by hybridization of two antimalarial pharmacophores.
format Online
Article
Text
id pubmed-6804225
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68042252019-11-18 Combination Therapy Strategies for the Treatment of Malaria Alven, Sibusiso Aderibigbe, Blessing Molecules Review Malaria is a vector- and blood-borne infection that is responsible for a large number of deaths around the world. Most of the currently used antimalarial therapeutics suffer from drug resistance. The other limitations associated with the currently used antimalarial drugs are poor drug bioavailability, drug toxicity, and poor water solubility. Combination therapy is one of the best approaches that is currently used to treat malaria, whereby two or more therapeutic agents are combined. Different combination therapy strategies are used to overcome the aforementioned limitations. This review article reports two strategies of combination therapy; the incorporation of two or more antimalarials into polymer-based carriers and hybrid compounds designed by hybridization of two antimalarial pharmacophores. MDPI 2019-10-07 /pmc/articles/PMC6804225/ /pubmed/31591293 http://dx.doi.org/10.3390/molecules24193601 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Alven, Sibusiso
Aderibigbe, Blessing
Combination Therapy Strategies for the Treatment of Malaria
title Combination Therapy Strategies for the Treatment of Malaria
title_full Combination Therapy Strategies for the Treatment of Malaria
title_fullStr Combination Therapy Strategies for the Treatment of Malaria
title_full_unstemmed Combination Therapy Strategies for the Treatment of Malaria
title_short Combination Therapy Strategies for the Treatment of Malaria
title_sort combination therapy strategies for the treatment of malaria
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804225/
https://www.ncbi.nlm.nih.gov/pubmed/31591293
http://dx.doi.org/10.3390/molecules24193601
work_keys_str_mv AT alvensibusiso combinationtherapystrategiesforthetreatmentofmalaria
AT aderibigbeblessing combinationtherapystrategiesforthetreatmentofmalaria